Literature DB >> 1678204

Interactions between non-steroidal anti-inflammatory drugs and H2-receptor antagonists or prostaglandin analogues.

J S Dixon1, M C Page.   

Abstract

Published pharmacokinetic studies investigating possible interaction between H2-receptor antagonists (n = 22) or prostaglandin analogues (n = 6) and nonsteroidal anti-inflammatory drugs (NSAIDs) have been reviewed. With two exceptions the studies were carried out in young, healthy male volunteers rather than in arthritis patients. In addition some of the studies were poorly designed and inadequately described. Cimetidine appeared to increase the area under the plasma concentration-time curve, and hence to decrease the apparent oral clearance, of several NSAIDs including piroxicam, indomethacin, flurbiprofen, sulindac, oxaprozin and aspirin, while ranitidine co-administration resulted in similar changes for oxyprozin alone. The data currently available for prostaglandin analogues are insufficient to draw firm conclusions. It therefore remains a possibility that clinically relevant pharmacokinetic interactions may occur in elderly arthritic patients, and this issue needs to be addressed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1678204     DOI: 10.1007/bf00290245

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  29 in total

1.  Pharmacokinetics of misoprostol in the elderly, in patients with renal failure and when coadministered with NSAID or antipyrine, propranolol or diazepam.

Authors:  P A Nicholson; A Karim; M Smith
Journal:  J Rheumatol Suppl       Date:  1990-02

2.  Prevention of NSAID-induced gastric ulcer with prostaglandin analogues.

Authors:  N Rietbrock; A Karim; P A Nicholson
Journal:  Lancet       Date:  1989-04-15       Impact factor: 79.321

Review 3.  Variability in response to NSAIDs. Fact or fiction?

Authors:  R O Day; G G Graham; K M Williams; P M Brooks
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

4.  Influence of cimetidine on the pharmacokinetics of piroxicam in rat and man.

Authors:  S A Said; A M Foda
Journal:  Arzneimittelforschung       Date:  1989-07

5.  The effect of cimetidine on the pharmacokinetics of salicylic acid.

Authors:  Z Trnavská; K Trnavský; J Smondrk
Journal:  Drugs Exp Clin Res       Date:  1985

6.  Effect of cimetidine on bioavailability of enteric-coated aspirin tablets.

Authors:  T W Paton; S E Walker; F Y Leung; A H Little
Journal:  Clin Pharm       Date:  1983 Mar-Apr

7.  Interaction of ibuprofen with the H-2 receptor antagonists ranitidine and cimetidine.

Authors:  H R Ochs; D J Greenblatt; R Matlis; J Weinbrenner
Journal:  Clin Pharmacol Ther       Date:  1985-12       Impact factor: 6.875

8.  The effect of cimetidine on serum concentrations of piroxicam.

Authors:  C Mailhot; S L Dahl; J R Ward
Journal:  Pharmacotherapy       Date:  1986 May-Jun       Impact factor: 4.705

Review 9.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

10.  [Ranitidine ameliorates acemetacin and indomethacin-induced changes of the gastroduodenal mucosa, without modifying the pharmacokinetic behavior of both antirheumatic drugs].

Authors:  P Müller; H G Dammann; M Langer; U Leucht; B Simon
Journal:  Z Gastroenterol       Date:  1989-02       Impact factor: 2.000

View more
  4 in total

Review 1.  Pharmacokinetic drug interactions with anti-ulcer drugs.

Authors:  R D Negro
Journal:  Clin Pharmacokinet       Date:  1998-08       Impact factor: 6.447

2.  Cimetidine does not alter the clearance or plasma binding of tenidap in healthy male volunteers.

Authors:  K D Wilner; M J Gardner
Journal:  Br J Clin Pharmacol       Date:  1995       Impact factor: 4.335

3.  Differential effects of misoprostol and ranitidine on the pharmacokinetics of diclofenac and gastrointestinal symptoms.

Authors:  H G Dammann; J Simon-Schultz; I Steinhoff; A Damaschke; A Schmoldt; E Sallowsky
Journal:  Br J Clin Pharmacol       Date:  1993-10       Impact factor: 4.335

Review 4.  Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  J R Brouwers; P A de Smet
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.